Literature DB >> 2667855

Circadian rhythm of glomerular filtration rate in normal individuals.

M G Koopman1, G C Koomen, R T Krediet, E A de Moor, F J Hoek, L Arisz.   

Abstract

1. In a group of 11 normal individuals we measured glomerular filtration rate (GFR) by inulin clearances and effective renal plasma flow (ERPF) by p-aminohippurate clearances during a period of 24 h and a regimen of bedrest, identical food intake per 3 h and normal sleep/wake and light/dark cycles. 2. All subjects had a circadian rhythm for GFR with a maximum of 122 ml/min (SD 22) in the daytime, a minimum of 86 ml/min (SD 12) at night and with a relative amplitude of 33% (SD 15). 3. ERPF had a circadian rhythm with a similar relative amplitude as the GFR rhythm, but with a different phase. Because of this difference in phase, the calculated filtration fraction (GFR/ERPF) followed a circadian rhythm as well. 4. The circadian rhythms of urine volume and sodium excretion were in phase with the GFR rhythm, but the potassium rhythm had a different phase, probably because urinary potassium is largely derived from tubular secretion. 5. Urinary albumin and beta 2-microglobulin excretion had a circadian rhythm in phase with the GFR rhythm. 6. The highest quantity of sodium, water and beta 2-microglobulin was reabsorbed in the daytime; tubular reabsorption, expressed as percentage of the filtered load (fractional reabsorption), had a rhythm with a reversed phase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667855     DOI: 10.1042/cs0770105

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  58 in total

1.  Circadian pattern in occurrence of renal colic in an emergency department: analysis of patients' notes.

Authors:  Roberto Manfredini; Massimo Gallerani; Olga la Cecilia; Benedetta Boari; Carmelo Fersini; Francesco Portaluppi
Journal:  BMJ       Date:  2002-03-30

2.  Circadian variation in urinary excretion of ciprofloxacin after a single-dose oral administration at 1000 and 2200 hours in human subjects.

Authors:  V V Rao; D Rambhau; B R Rao; P Srinivasu
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Variability of urinary cadmium excretion in spot urine samples, first morning voids, and 24 h urine in a healthy non-smoking population: implications for study design.

Authors:  Magnus Akerstrom; Lars Barregard; Thomas Lundh; Gerd Sallsten
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-09-11       Impact factor: 5.563

Review 4.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 5.  Essentials of laboratory medicine for the nephrology clinician.

Authors:  Tarak Srivastava; Uttam Garg; Y Raymond Chan; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

6.  Obstructive sleep apnoea syndrome promotes reversal albuminuria during sleep.

Authors:  Euphemia G Daskalopoulou; Christos Liavvas; Christos T Nakas; Emmanuel G Vlachogiannis; Demosthenes Bouros; Nicholas V Dombros
Journal:  Sleep Breath       Date:  2010-09-25       Impact factor: 2.816

7.  Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.

Authors:  Per Olsson-Gisleskog; Philippe Jacqmin; Juan Jose Perez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

9.  Desoxycorticosterone pivalate-salt treatment leads to non-dipping hypertension in Per1 knockout mice.

Authors:  K Solocinski; M Holzworth; X Wen; K-Y Cheng; I J Lynch; B D Cain; C S Wingo; M L Gumz
Journal:  Acta Physiol (Oxf)       Date:  2016-10-03       Impact factor: 6.311

10.  Biological Variability of Estimated GFR and Albuminuria in CKD.

Authors:  Sushrut S Waikar; Casey M Rebholz; Zihe Zheng; Shelley Hurwitz; Chi-Yuan Hsu; Harold I Feldman; Dawei Xie; Kathleen D Liu; Theodore E Mifflin; John H Eckfeldt; Paul L Kimmel; Ramachandran S Vasan; Joseph V Bonventre; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2018-07-18       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.